New Market Perspective
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

New Market Perspective

Politics

Greene calls for yanking FDA approval of COVID-19 vaccines: ‘Causing permanent harm and deaths’

by admin March 21, 2025
March 21, 2025
Greene calls for yanking FDA approval of COVID-19 vaccines: ‘Causing permanent harm and deaths’

Rep. Marjorie Taylor Greene, R-Ga., declared that U.S. Food and Drug Administration approval for COVID-19 vaccines should be yanked, asserting that the jabs ‘are causing permanent harm and deaths.’

‘FDA approval for COVID-19 vaccines needs to be pulled and they need taken off the childhood vaccine schedule ASAP,’ she said Thursday in a post on X. ‘I’ve been saying this ever since they were created and my personal Twitter account was permanently banned for my outspoken stance against the vaccines until Elon Musk bought Twitter, changed it to X, and restored my account along with thousands of people who were censored and silenced.’

The child and adolescent immunization schedule on the Centers for Disease Control and Prevention website includes COVID-19 vaccine recommendations for children 6 months old and above.

Greene contends that the jabs should never have been approved in the first place.

‘COVID-19 vaccines should have never received approval and they’ve known the entire time how bad the side effects are and deaths caused by them. It’s time to do the right thing. Stop the COVID-19 vaccines,’ she declared in her post.

But the CDC notes, ‘COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. There is currently no FDA-approved or FDA-authorized COVID-19 vaccine for children younger than age 6 months. CDC recommends that people stay up to date with COVID-19 vaccination.’

‘Cases of myocarditis and pericarditis have rarely been observed following receipt of COVID-19 vaccines used in the United States,’ the CDC indicates.

‘Evidence from multiple monitoring systems support a causal association for mRNA COVID-19 vaccines (Moderna or Pfizer-BioNTech) and myocarditis and pericarditis. Cases have occurred most frequently in adolescent and young adult males within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Moderna and Pfizer-BioNTech); however, cases have also been observed in females and after other doses.’

Rep. Thomas Massie has also expressed the view that the FDA should nix approval for the COVID-19 vaccines. 

‘FDA should immediately revoke approval of these shots,’ he tweeted last month.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Bernie Sanders, AOC take aim at Trump and Musk, as well as Democrats, at western rallies
next post
Canadian politician claims Trump admin’s ’51st state’ rhetoric is an ‘act of war’

Related Posts

Theme of Trump’s address to Congress revealed

March 4, 2025

DAVID MARCUS: A comedy legend trashes his rep...

November 5, 2024

House Republicans push to rename DC international airport...

April 2, 2024

The three mountains in the way of any...

November 15, 2024

Which social media platforms have banned Trump and...

August 5, 2024

Iran’s Ayatollah Ali Khamenei in hiding with extra...

September 29, 2024

Secret Service failures during Trump rally spur concerns...

July 24, 2024

House Republicans unveil new food stamp work requirements...

May 13, 2025

How technology has changed inauguration coverage

January 20, 2025

Ex-Obama official predicts Harris will seek new Iran...

August 28, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • White House reveals highest-paid staffers–and 8 taking no salaries

      July 3, 2025
    • Trump $3.3T megabill sets House record for longest vote in history

      July 3, 2025
    • Iran nuclear program set back 2 years after US strikes: Pentagon

      July 3, 2025
    • Airlines secretly sold US travelers’ data to Homeland Security

      July 3, 2025
    • White House reveals highest-paid staffers – and 8 taking no salaries

      July 3, 2025
    • Jeffries stalls Trump’s ‘big, beautiful bill’ for hours after House GOP mutiny breakthrough

      July 3, 2025

    Popular

    • 1

      Top 5 Junior Copper Stocks on the TSXV in 2023

      December 22, 2023
    • 2

      Crypto Market 2023 Year-End Review

      December 22, 2023
    • 3

      Canada Silver Cobalt Begins Drilling at Lowney-Lac Edouard in Quebec, Targeting Nickel-Copper-Cobalt Mineralization

      December 22, 2023
    • 4

      10 Top Oil-producing Countries (Updated 2024)

      October 19, 2024
    • 5

      Top 10 Uranium-producing Countries (Updated 2024)

      April 18, 2024
    • 6

      Powered by rain, this seed carrier could help reforest the most remote areas

      December 19, 2023
    • 7

      A troubling theory about traders profiting from Hamas’ attack on Israel drew much attention. Why it may not be so simple.

      December 13, 2023

    Categories

    • Business (1,397)
    • Investing (3,435)
    • Politics (4,507)
    • World (4,410)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: newmarketperspective.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 newmarketperspective.com | All Rights Reserved